Glioblastoma multiforme Clinical Research Trials

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Los Angeles : UCLA Neuro-Oncology Program Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Newport Beach : Hoag Memorial Hospital Presbyterian Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Newport Beach : Hoag Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Sacramento : Sutter Institute for Medical Research Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

San Francisco : University of California at San Francisco Updated

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

San Francisco : University of California at San Francisco Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

South Pasadena : South Pasadena Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Aurora : University of Colorado Denver, University of Colorado Cancer Center

Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

Jacksonville : Call for Information (Investigational Site 0002)

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Miami Beach : Mount Sinai CCOP Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Orlando : MD Anderson Cancer Center Orlando

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Tampa : Moffitt Cancer Center & Research Institute Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Chicago : Northwestern Memorial Hospital

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Chicago : Rush University Medical Center

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Chicago : Northwestern University Feinberg School of Medicine

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Chicago : University of Illinois at Chicago

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Chicago : Rush University Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : University of Illinois Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : Northwestern University - Robert H Lurie Comprehensive Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Peoria : Illinois Cancer Care Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Indianapolis : IU Simon Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lexington : University of Kentucky - Markey Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Louisville : Jewish Hospital Medical Center

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Scarborough : Maine Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Boston : Massachusetts General Hospital

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Boston : Tufts Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Boston : Dana-Farber Cancer Institute

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Boston : Massachusetts General Hospital

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Boston : Tufts Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Burlington : Lahey Clinic Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Ann Arbor : University of Michigan, Department of Neurosurgery Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Detroit : Henry Ford Health Systems

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Detroit : Henry Ford Hospital

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Detroit : Henry Ford Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Detroit : Henry Ford Hospital

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Minneapolis : Virginia Piper Cancer Institute Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rochester : Call for Information (Investigational Site 0005)

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Kansas City : St. Luke's Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Kansas City : Saint Luke's Hospital

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Saint Louis : Washington University

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

St. Louis : Washington University School of Medicine Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lebanon : Dartmouth Hithcock Medcial Center

Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)

Edison : New Jersey Neuroscience Institute

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Edison : New Jersey Neuroscience Center - JFK Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Edison : JFK Medical Center

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Hackensack : John Theurer Cancer Center at Hackensack University Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

New Brunswick : Cancer Institute of New Jersey

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Summit : Overlook Hospital

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Summit : Overlook Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Manhasset : Biomedical Research Alliance of New York

Glioblastoma (Brain Tumor) and Unmethylated MGMT Gene - Adults

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

Amherst : Dent Neurologic Institute

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C. Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Great Neck : The Long Island Brain Tumor Center at Neurological Surgery, PC

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Huntington : Huntington Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lake Success : North Shore - Long Island Jewish Hospital/Monter Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Manhasset : North Shore University Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Mineola : Winthrop University Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : NYU Clinical Cancer Center

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

New York : Investigational Site Number 165464

A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

New York : Weill Cornell Medical College

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : The New York Hospital/ Weill Medical College

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

New York : New York University Clinical Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : NYU Cancer Institute Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Oceanside : South Nassau Community Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rochester : University of Rochester Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rockville Centre : Mercy Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chapel Hill : University of North Carolina Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Durham : The Preston Robert Tisch Brain Tumor Center

AMG 102 and Avastin for Recurrent Malignant Glioma

Durham : Duke University Medical Center

Amgen 386 for Recurrent Glioblastoma

Durham : Duke University Medical Center

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Durham : The Preston Robert Tisch Brain Tumor Center

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Winston Salem : Wake Forest University

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Winston-Salem : Derrick L Davis Forsyth Regional Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Cincinnati : University of Cincinnati

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Cincinnati : UC Cancer Institute Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : Case Comprehensive Cancer Center

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Cleveland : Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Cleveland : Cleveland Clinic Taussig Cancer Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Cleveland : Cleveland Clinic

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Cleveland : Cleveland Clinic Foundation Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : University Hospitals of Cleveland Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Columbus : Ohio State University

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Columbus : The Ohio State University - James Comprehensive Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Portland : Oregon Health and Sciences University

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Providence Cancer Center

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Danville : Geisinger Health System

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Hershey : Penn State Hershey Medical Center

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Philadelphia : Thomas Jefferson University

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Philadelphia : University of Pennsylvania

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Pittsburgh : University of Pittsburgh Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Providence : Rhode Island Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Charleston : Medical University of South Carolina Hospitals and Clinics Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Tennessee Oncology

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Nashville : Sarah Cannon Research Institute

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Nashville : St. Thomas Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Vanderbilt Ingram Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit Updated

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Nashville : Sarah Cannon Research Institute (SCRI) Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Dallas : Sammons Cancer Center (Baylor)

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Dallas : Baylor Research Institute

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Dallas : Baylor

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Dallas : Baylor Research Institute Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Dallas : Mary Crowley Cancer Research Centers Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Dallas : Baylor University Medical Center

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Houston : University of Texas Health Science Center at Houston

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Houston : The University of Texas Health Science Center at Houston

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : Methodist Hospital

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : Methodist Neurological Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : UT MD Anderson Cancer Center

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Houston : Call for Information (Investigational Site 0001)

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Houston : UT MD Anderson Cancer Center

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

Charlottesville : University of Virginia Health System

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Seattle : Swedish Neuroscience Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seattle : Swedish Hospital Neuroscience Research Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Green Bay : Aurora BayCare Medical Center

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Feldkirch : Landeskrankenhaus Feldkirch

Dendritic Cell Cancer Vaccine for High-grade Glioma

Graz : University Hospital Graz

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Innsbruck : Medical University Innsbruck

Dendritic Cell Cancer Vaccine for High-grade Glioma

Linz : Landesnervenklinik Wagner-Jauregg

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Kaiser Franz-Josef Spital

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Medical University Vienna

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Donauspital, SMZ-Ost

Dendritic Cell Cancer Vaccine for High-grade Glioma

Prague : Jan Sroubek

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Copenhagen : Updated

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Lyon : Hospital of Neurology Lyon - University Claude Bernard

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Marseille : Updated

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Paris : Group Hospitals Pitie-Salpetriere

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Toulouse : Centre Hospitalo-Universitaire de Toulouse Purpan

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Toulouse Cedex : Institut Claudius Régaud Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Villejuif Cedex : Institut Gustave Roussy, Dept. of Medicine Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Berlin : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bochum : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bonn : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Chemnitz : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Dresden : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Düsseldorf : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Erfurt : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Frankfurt : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Freiburg : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Göttingen : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Hamburg : University Medical Center Hamburg-Eppendorf

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Heidelberg : Medical University Heidelberg

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Heidelberg : Department of Neurosurgery, University Hospital Heidelberg

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Heidelberg : University of Heidelberg

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Kiel : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Kiel : University Hospital of Schleswig-Holstein

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Köln : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Leipzig : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Mannheim : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

München : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Regensburg : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Tübingen : Updated

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Tel Aviv : Tel Aviv Sourasky Medical Center

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Bologna : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Genova : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Milan : Foundation Hospital Greater Policlinico

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Milan : C. Besta Neurological Institute

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Milano : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Padova : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Roma : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Rome : Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

San Giovanni Rotondo : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Terni : Updated

A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma

Salamanca : Hospital Universitario de Salamanca Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Seville : Servicio de Oncologia Medica Sala de Investigación Updated

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV)

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Zürich : Updated

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Manchester : Updated

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Washington : Georgetown University Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Clinical Trials: Glioblastoma multiforme

Alabama

Arizona

California

Colorado

Florida

Illinois

Indiana

Kentucky

Maine

Massachusetts

Michigan

Minnesota

Missouri

New Hampshire

New Jersey

New York

North Carolina

Ohio

Oregon

Pennsylvania

Rhode Island

South Carolina

Tennessee

Texas

Virginia

Washington

Wisconsin

Austria

Czech Republic

Denmark

France

Germany

Israel

Italy

Spain

Switzerland

United Kingdom

United States